Sanara Medtech Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Sanara Medtech Stock Summary

Sanara Medtech competes with InfuSystems Holdings, Pro Dex, LeMaitre Vascular, Utah Medical, and Milestone Scientific. Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. Sanara Medtech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.

Sanara Medtech Key Financial Ratios

Sanara Medtech Key Balance Sheet Accounts

Sanara Medtech Key Income Statement Accounts

Sanara Medtech Key Cash Accounts

Sanara Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sanara Medtech's current stock value. Our valuation model uses many indicators to compare Sanara Medtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sanara Medtech competition to find correlations between indicators driving Sanara Medtech's intrinsic value. More Info.Sanara Medtech is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Sanara Medtech's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sanara Medtech's earnings, one of the primary drivers of an investment's value.

Sanara Medtech Systematic Risk

Today, most investors in Sanara Medtech Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sanara Medtech's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sanara Medtech growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Sanara Medtech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sanara Medtech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sanara Medtech based on widely used predictive technical indicators. In general, we focus on analyzing Sanara Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sanara Medtech's daily price indicators and compare them against related drivers.

When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.